Rule 10b5-1 Issuer Repurchase PlanRepurchase Plan • February 28th, 2023 • Fulgent Genetics, Inc. • Services-medical laboratories
This Rule 10b5-1 Issuer Repurchase Plan (this “Plan”) is entered into this 15th day of December, 2022 between Fulgent Genetics, Inc. (“Company”) and Piper Sandler & Co. (“Broker”).
SECOND AMENDMENT TO LEASE AGREEMENTLease Agreement • February 28th, 2023 • Fulgent Genetics, Inc. • Services-medical laboratories
THIS SECOND AMENDMENT TO LEASE AGREEMENT (this "Second Amendment") dated and effective for reference purposes as of July 1, 2020, is made by and between WPT LAND 2 LP, a Delaware limited partnership ("Landlord), and INFORM DIAGNOSTICS, INC., a Delaware corporation ("Tenant).
LEASE OF PREMISES AT 15-19 CRAWFORD STREET NEEDHAM, MASSACHUSETTS FROM CRAWFORD STREET DE, LLC TO MIRACA LIFE SCIENCES, INC.Lease • February 28th, 2023 • Fulgent Genetics, Inc. • Services-medical laboratories
THIS LEASE (this “Lease”), made as of the 17th day of January, 2017, between Crawford Street DE, LLC, a Delaware limited liability company, and Miraca Life Sciences, Inc., a Delaware corporation, is as follows.
FIRST AMENDMENT AND PARTIAL RESTATEMENT OF LEASERestatement of Lease • February 28th, 2023 • Fulgent Genetics, Inc. • Services-medical laboratories
THIS First Amendment and Partial Restatement of Lease (this “Amendment”) is entered into as of December 30, 2013 (the “Effective Date”), between LC MED PROPERTY TT, LLC, a Delaware limited liability company (“Landlord”), successor-in-interest to iStar CTL I, L.P. (“Original Landlord”), and MIRACA LIFE SCIENCES, INC., a Delaware corporation (“Tenant”), successor-in-interest to Caris Diagnostics, Inc. (“Original Tenant”).
SECOND AMENDMENT TO LEASELease • February 28th, 2023 • Fulgent Genetics, Inc. • Services-medical laboratories
THIS Second Amendment to Lease (this “Amendment”) is entered into as of February 3, 2014 (the “Effective Date”), between LC MED PROPERTY TT, LLC , a Delaware limited liability company (“Landlord”), successor-in-interest to iStar CTL I, L.P. (“Original Landlord”), and MIRACA LIFE SCIENCES, INC., a Delaware corporation (“Tenant”), successor-in interest to Caris Diagnostics, Inc. (“Original Tenant”).
